Striatal Cannabinoid CB1 Receptor mRNA Expression Is Decreased in the Reserpine-Treated Rat Model of Parkinson's Disease

This publication has 36 references indexed in Scilit:

• Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
  The FASEB Journal, 2000
• Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
  Trends in Neurosciences, 1998
• Topographical Organization of Opioid Peptide Precursor Gene Expression Following Repeated Apomorphine Treatment in the 6-Hydroxydopamine-Lesioned Rat
  Experimental Neurology, 1998
• Novel approaches to the symptomatic treatment of parkinsonian syndromes
  Current Opinion in Neurology, 1997
• Formation and inactivation of endogenous cannabinoid anandamide in central neurons
  Nature, 1994
• Chapter 8 Chemical signalling in the globus pallidus in parkinsonism
  Published by Elsevier ,1993
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992
• Primate models of movement disorders of basal ganglia origin
  Trends in Neurosciences, 1990
• Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat
  Neuropharmacology, 1987
• 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
  Nature, 1957